{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T05:36:42Z","timestamp":1784698602378,"version":"3.55.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL158517"],"award-info":[{"award-number":["R01 HL158517"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL160761"],"award-info":[{"award-number":["R01 HL160761"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008523","name":"Center for Clinical and Translational Science, University of Illinois at Chicago","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008523","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011542","name":"Center for Clinical and Translational Science, Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.ijcard.2023.131152","type":"journal-article","created":{"date-parts":[[2023,7,8]],"date-time":"2023-07-08T19:15:34Z","timestamp":1688843734000},"page":"131152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Clinical benefits of angiotensin receptor-Neprilysin inhibitor in adults with congenital heart disease"],"prefix":"10.1016","volume":"387","author":[{"given":"Kartik","family":"Andi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Abozied","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R.","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason H.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi M.","family":"Connolly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Charles","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke J.","family":"Burchill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander C.","family":"Egbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2023.131152_bb0005","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2023.131152_bb0010","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone evaluation study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"62","key":"10.1016\/j.ijcard.2023.131152_bb0015","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association task force on practice guidelines","volume":"2013","author":"Yancy","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2023.131152_bb0020","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.cardfail.2011.03.005","article-title":"Heart failure with recovered ejection fraction: a distinct clinical entity","volume":"17","author":"Punnoose","year":"2011","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.ijcard.2023.131152_bb0025","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1161\/CIRCULATIONAHA.113.006855","article-title":"Heart failure with recovered ejection fraction: clinical description, biomarkers, and outcomes","volume":"129","author":"Basuray","year":"2014","journal-title":"Circulation."},{"key":"10.1016\/j.ijcard.2023.131152_bb0030","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1161\/CIRCULATIONAHA.114.013748","article-title":"Investigators P-H and coordinators. Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure","volume":"131","author":"Packer","year":"2015","journal-title":"Circulation."},{"key":"10.1016\/j.ijcard.2023.131152_bb0035","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"2022 AHA\/ACC\/HFSA guideline for the Management of Heart Failure: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2023.131152_bb0040","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/ejhf.2333","volume":"24","author":"Authors\/Task Force M","year":"2022","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2023.131152_bb0045","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1177\/2150135119825599","article-title":"Early experience with Sacubitril\/valsartan in adult patients with congenital heart disease","volume":"10","author":"Lluri","year":"2019","journal-title":"World J. Pedia. Congen. Heart Surg."},{"key":"10.1016\/j.ijcard.2023.131152_bb0050","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ijcard.2019.06.031","article-title":"Sacubitril\/valsartan for heart failure in adults with complex congenital heart disease","volume":"300","author":"Maurer","year":"2020","journal-title":"Int. J. Cardiol."},{"issue":"71","key":"10.1016\/j.ijcard.2023.131152_bb0055","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.jacc.2017.12.048","article-title":"2017 Cardiovascular and stroke endpoint definitions for clinical Trials","author":"Hicks","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2023.131152_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2018.06.004","article-title":"Guidelines for performing a comprehensive transthoracic echocardiographic examination in adults: recommendations from the American Society of Echocardiography","volume":"32","author":"Mitchell","year":"2019","journal-title":"J. Am. Soc. Echocardiogr.: Off. Publ. Am. Soc. Echocardiogr."},{"issue":"1\u201339","key":"10.1016\/j.ijcard.2023.131152_bb0065","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"28","author":"Lang","year":"2015","journal-title":"J. Am. Soc. Echocardiogr.: Off. Publ. Am. Soc. Echocardiogr."},{"key":"10.1016\/j.ijcard.2023.131152_bb0070","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/ehjci\/jey042","volume":"19","author":"Badano","year":"2018","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"10.1016\/j.ijcard.2023.131152_bb0075","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1093\/ehjci\/jeab165","article-title":"Prognostic implications of left heart diastolic dysfunction in adults with coarctation of aorta","volume":"22","author":"Egbe","year":"2021","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"issue":"14","key":"10.1016\/j.ijcard.2023.131152_bb0080","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1136\/heartjnl-2020-317756","article-title":"Haemodynamic determinants of improved aerobic capacity after tricuspid valve surgery in Ebstein anomaly","volume":"107","author":"Egbe","year":"2021","journal-title":"Heart."},{"key":"10.1016\/j.ijcard.2023.131152_bb0085","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/pst.433","article-title":"Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies","volume":"10","author":"Austin","year":"2011","journal-title":"Pharm. Stat."},{"key":"10.1016\/j.ijcard.2023.131152_bb0090","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1016\/j.jacc.2018.08.1029","article-title":"2018 AHA\/ACC guideline for the Management of Adults with Congenital Heart Disease: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines","volume":"73","author":"Stout","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2023.131152_bb0095","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.hlc.2018.12.003","article-title":"Sacubitril\/valsartan in adult congenital heart disease patients with chronic heart failure - a single centre case series and call for an international registry","volume":"29","author":"Appadurai","year":"2020","journal-title":"Heart, Lung Circul."},{"key":"10.1016\/j.ijcard.2023.131152_bb0100","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1136\/heartjnl-2020-318074","article-title":"Sacubitril\/valsartan in the treatment of systemic right ventricular failure","volume":"107","author":"Zandstra","year":"2021","journal-title":"Heart."},{"key":"10.1016\/j.ijcard.2023.131152_bb0105","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.echo.2010.05.010","volume":"23","author":"Rudski","year":"2010","journal-title":"J. Am. Soc. Echocardiogr.: Off. Publ. Am. Soc. Echocardiogr."},{"key":"10.1016\/j.ijcard.2023.131152_bb0110","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.jacc.2022.01.040","article-title":"Prevalence and prognostic implications of left ventricular systolic dysfunction in adults with congenital heart disease","volume":"79","author":"Egbe","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2023.131152_bb0115","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1136\/heartjnl-2020-317756","article-title":"Haemodynamic determinants of improved aerobic capacity after tricuspid valve surgery in Ebstein anomaly","volume":"107","author":"Egbe","year":"2021","journal-title":"Heart."},{"key":"10.1016\/j.ijcard.2023.131152_bb0120","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1016\/j.jacc.2020.10.035","article-title":"Prognostic role of hepatorenal function indexes in patients with Ebstein anomaly","volume":"76","author":"Egbe","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2023.131152_bb0125","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1016\/j.ijcard.2013.03.003","article-title":"Heart failure admissions in adults with congenital heart disease; risk factors and prognosis","volume":"168","author":"Zomer","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2023.131152_bb0130","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1161\/CIRCULATIONAHA.105.543470","article-title":"Angiotensin receptor blockade and exercise capacity in adults with systemic right ventricles: a multicenter, randomized, placebo-controlled clinical trial","volume":"112","author":"Dore","year":"2005","journal-title":"Circulation."},{"key":"10.1016\/j.ijcard.2023.131152_bb0135","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1161\/CIRCULATIONAHA.112.135392","article-title":"Effect of valsartan on systemic right ventricular function: a double-blind, randomized, placebo-controlled pilot trial","volume":"127","author":"van der Bom","year":"2013","journal-title":"Circulation."},{"key":"10.1016\/j.ijcard.2023.131152_bb0140","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1161\/01.CIR.0000020009.30736.3F","article-title":"Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease","volume":"106","author":"Bolger","year":"2002","journal-title":"Circulation."},{"key":"10.1016\/j.ijcard.2023.131152_bb0145","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.jcmg.2021.09.016","article-title":"Prognostic implications of progressive systemic ventricular dysfunction in congenitally corrected transposition of great arteries","volume":"15","author":"Egbe","year":"2022","journal-title":"J. Am. Coll. Cardiol. Img."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527323009592?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527323009592?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T21:02:47Z","timestamp":1759093367000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527323009592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":29,"alternative-id":["S0167527323009592"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2023.131152","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical benefits of angiotensin receptor-Neprilysin inhibitor in adults with congenital heart disease","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2023.131152","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"131152"}}